The weight-loss drug revolution

We hear how karate, being laughed out of a bank boardroom in a cash-obsessed country helped shape one of India’s most valuable fintech companies. Harshil Mathur shares how discipline, resilience and a leap of faith helped him build Razorpay into a $7.5 billion company at the hear ...  Show more

Headspace started life as a mindfulness app. Now it's partnering with the US Navy and investing in artificial intelligence for mental health support.The company's CEO Tom Pickett speaks to us about therapy, the increasing role of technology, and tackling burnout at scale.If you'd ...  Show more

It’s become a multibillion-dollar business: weight loss drugs. Demand is high, as is the cost. How did medications like Ozempic, Wegovy, Mounjaro and Zepbound become so popular and so profitable? And what kind of impact might they have on the future of food and healthcare? Dr. Sa ...  Show more

Weight loss drug sales are estimated to hit $44 billion by 2030. Many of these treatments can thank previously obscure research on a carnivorous deep sea fish for their development. Rolfe Winkler is a reporter for the Wall Street Journal covering digital health. Ricky Mulvey cau ...  Show more

Drugs like Ozempic are revolutionizing the treatment of obesity. The medications, originally used to treat diabetes, keep gaining attention as celebrities and other influencers describe taking them to lose weight quickly.

Dani Blum, a reporter for The Times, tells the st ...

As new weight management medications are being developed, might the obesity market parallel the likes of hypertension or high blood pressure to become the next blockbuster Pharma category?

----- Transcript -----

Welcome to Thoughts on the Mark ...